The score and its parameters are based on a retrospective analysis in a single center setting and a prospective evaluation in the same center (32, 33) and includes the standard PRISM score and three additional variables (CRP, GVHD and hemorrhage). This evidence concerns the gene CRP and graft versus host disease.